• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
February 5th - Recently, several automakers have launched "7-year ultra-long-term low-interest" products. A reporter visited several automakers direct-sales stores. An employee of a domestic brand stated that their SUV model, priced around 200,000 yuan, with zero down payment and a 7-year loan, would have a monthly payment of approximately 2,700 yuan, with total interest of approximately 26,000 yuan, about half the interest rate of a traditional bank loan. However, this type of loan differs from traditional bank loans; some automakers 7-year loans require a minimum repayment period of 3 years before full prepayment can be made.The China Earthquake Networks Center officially reported that a 4.5-magnitude earthquake occurred in Kazakhstan (44.71 degrees north latitude, 79.74 degrees east longitude) at 16:39 on February 5, with a focal depth of 20 kilometers.February 5th - Shanghai Henlius Biotech (02696.HK) announced that it has entered into a licensing agreement with Japanese pharmaceutical company Eisai Co., Ltd., under which the company will grant Eisai an exclusive license to commercialize its licensed product Hanszal® (Slulimab injection) in the region and field. Eisai will pay the company an upfront payment of US$75 million, regulatory milestone payments totaling up to US$80.01 million based on the achievement of various regulatory milestones for the licensed product in the region, and commercial sales milestone payments totaling up to US$233.33 million based on the achievement of annual net sales of the licensed product in the region, plus royalties calculated as a double-digit percentage of the annual net sales of the licensed product in the region.Volkswagen shares fell 3.2%, poised for their biggest one-day drop since September 2025.February 5th - Hengrui Medicine announced that it recently received an Acceptance Notice from the National Medical Products Administration (NMPA) for its marketing authorization application for HR091506 tablets. HR091506 tablets are febuxostat oral sustained-release tablets with pulsatile release characteristics, independently developed by the company using gastric retention formulation technology. The product consists of an immediate-release portion and a delayed-release portion. After oral administration, the immediate-release portion is rapidly released in the stomach to achieve an effective blood drug concentration; the delayed-release portion remains in the stomach for sustained release, aiming to prolong the duration of effective blood drug concentration and improve the rate of uric acid reduction.

WTI Price Analysis: Rebounds from 50% Fibo./100-period SMA support confluence

Alina Haynes

Oct 17, 2022 14:46

截屏2022-10-17 下午2.39.40.png 

 

The price of WTI crude oil regains some positive momentum on the opening day of a new week and maintains its position above the $85.00 threshold heading into the European session.

 

From a technical standpoint, the commodity defends the $84.50-$84.25 confluence combining the 4-hour 100-period SMA and the 50% Fibonacci retracement level of the $76.08-$92.63 advance. The aforementioned region should now serve as a crucial turning point, which, if decisively broken, will pave the way for a continuation of the recent rapid drop from the highest level since August reached last week.

 

In the interim, any future advance is likely to encounter resistance between $85.70-$85.75. This is closely followed by the $86.00 mark and the 38.2% Fibonacci level in the $86.30 region, over which current prices might reach $87.00. The momentum may extend into the $87.45 barrier en route to the $88.00 mark and the 23.6% Fibonacci level, in the $88.55-$88.60 supply zone.

 

In contrast, weakening below the $85.00 round number may continue to find support near the intersection of $84.50 and $84.25. A convincing break below will serve as a new catalyst for pessimistic traders and pave the way for further declines. The price of WTI crude oil might possibly decline below $84,00 and test the next key support between $83.40-$83.35 before falling to the $83.00 level.